Curis, Inc(NASDAQ:CRIS) 
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CA-4948, an oral small molecule drug candidate, which is in Phase I clinical trial for the treatment o...
Website: http://www.curis.com
Founded: 2000
Full Time Employees: 28
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.30
H 1.42
L 1.19
C 1.23
V 160,808
10EMA 1.23
20EMA 1.23
60EMA 1.23
120EMA 1.23
250EMA 1.23